Latest disclosed round
Series B
- Date
- 2024-04-01
- Amount
- USD 24m
- Sector
- Biotech & techbio
- Companies House
- 11830661
Series B
Biofidelity
Genomics / liquid biopsy diagnostics
CandidateSeries BCambridge
Evidence status
Review retained
- Identity
- Candidate
- Match
- High candidate
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
4 linked investors
Funding record
1 disclosed round
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2024-04-01 | Series B | $24M | not specified in source, Agilent Technologies, Octopus Ventures, BlueYard Capital, Longwall Ventures |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.